Australia Poised to Vaccinate a Generation of Women

Australia Poised to Vaccinate a Generation of Women

Melbourne, Australia — 29/11/2006

CSL Limited welcomes today‚Äôs announcement by the Prime Minister and the Minister for Health that the Commonwealth Government will make GARDASIL®, the world’s first cervical cancer vaccine, available for school girls aged 12 to 18 years under the Government-funded National Immunisation Program (NIP). In addition, a free vaccine
program for women aged 19 -26 will be delivered by General Practitioners. In total, over 1 million Australian women and girls will be covered by the program.

CSL advises that it will be able to deliver the vaccine in time for the immunisation program to commence in 2007.

“CSL has worked closely with the Government to make GARDASIL available to Australian women as soon as possible, and this has involved fine tuning various aspects of our submission including some areas that have overall cost implications,” CSL’s CEO, Dr Brian McNamee said today.

‘The combination of a national immunisation program with GARDASIL, and regular two yearly pap smears means that we could substantially reduce the burden of cervical cancer and pre-cancers –State and Federal Governments now need to move to implement this program quickly.” he said.

The schools-based program is expected to start on April 1 2007. and the GP program midyear. The Government advises that it expects to spend a total of $436 million on the purchase of the vaccine over a four year period.

Download this release: PDF icon Australia Poised to Vaccinate a Generation of Women Against Cervical Cancer

Media Contacts

Dr Rachel David
CSL Limited
Director of Public Affairs
Phone: 0401 775 779

Andrew Parker
Parker & Partners
Phone: 0411 105 477
© 2017 CSL Limited